PTCT Shares Outstanding History



Below is a table of the PTCT shares outstanding history going back to 6/20/2013:

Date PTCT Shares Outstanding
6/20/201322.21M
8/12/201324.92M
11/13/201324.92M
3/4/201430.08M
5/5/201430.07M
8/4/201430.07M
11/5/201433.60M
2/24/201533.69M
4/30/201533.85M
7/28/201534.27M
11/4/201534.27M
2/24/201634.27M
5/2/201634.27M
8/1/201634.25M
11/1/201634.32M
2/24/201734.56M
5/5/201741.24M
8/4/201741.39M
10/31/201741.49M
2/28/201841.80M
5/4/201846.45M
8/3/201846.71M
11/1/201850.45M
2/25/201958.40M
4/29/201958.43M
8/5/201958.95M
10/25/201961.63M
2/27/202062.63M
4/28/202062.88M
8/3/202067.70M
10/27/202068.24M
2/23/202170.32M
5/3/202170.46M
7/28/202170.60M
10/27/202170.70M
2/18/202271.36M
5/2/202271.34M
8/2/202271.54M
10/25/202271.88M
2/16/202373.82M
4/25/202374.19M
8/1/202375.34M
10/24/202375.46M
2/27/202476.61M

Also see: PTCT Market Cap History
PTCT YTD Return
PTCT Historical Shares Outstanding:
+12.27% CAGR
PTCT Historical Shares Outstanding: +12.27% CAGR

Mouse over chart for data details
6/20/2013 ...2/27/2024
PTC Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of medicines. Co. has a portfolio pipeline that includes several commercial products and product candidates focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology, metabolism and oncology. Co. has two products, Translarna™ (ataluren) and Emflaza® (deflazacort), for the treatment of Duchenne muscular dystrophy, or DMD. Translarna is designed for the treatment of nonsense mutation DMD in ambulatory patients aged two years and older Emflaza is designed for the treatment of DMD in patients two years and older. We show 44 historical shares outstanding datapoints in our coverage of PTCT's shares outstanding history.

Understanding the changing numbers of PTCT shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like PTCT versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching PTCT by allowing them to research PTCT shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree PTCT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
PTC Therapeutics (PTCT) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

PTE Shares Outstanding History
PTGX Shares Outstanding History
PTI Shares Outstanding History
PTIE Shares Outstanding History
PTIX Shares Outstanding History
PTLA Shares Outstanding History
PTPI Shares Outstanding History
PTX Shares Outstanding History
PULM Shares Outstanding History
PXMD Shares Outstanding History
More Healthcare companies »

 

PTCT Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.